← Back to Search

Behavioral Intervention

Tweet2Quit for Smoking Cessation (Tweet2Quit Trial)

Phase 2
Waitlist Available
Led By Connie (Cornelia) Pechmann, PhD, MBA, MS
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Lives in the continental USA
Are 21-59 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month
Awards & highlights

Tweet2Quit Trial Summary

This study is evaluating whether a smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging is more effective than usual care.

Tweet2Quit Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Tweet2Quit Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants with a 6-month sustained abstinence
Secondary outcome measures
Percentage of participants with a 3-month sustained abstinence
Other outcome measures
Percentage of participants with a 7-Day point prevalence abstinence

Tweet2Quit Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: NRT + Web Guide + Tweet2Quit-WomenExperimental Treatment3 Interventions
Experimental: NRT + Web Guide + Tweet2Quit-Women NCI Smokefree.gov plus 8 weeks of combination NRT (nicotine patch plus gum/lozenges) plus assignment to a women-only Tweet2Quit group
Group II: NRT + Web Guide + Tweet2Quit-CoedExperimental Treatment3 Interventions
NCI Smokefree.gov plus 8 weeks of combination NRT (nicotine patch plus gum/lozenges) plus assignment to a coed Tweet2Quit group
Group III: NRT + Web GuideActive Control2 Interventions
NCI Smokefree.gov plus 8 weeks of combination NRT (nicotine patch plus gum/lozenges)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tweet2Quit
2016
Completed Phase 2
~960
NRT
2016
Completed Phase 2
~1260
Web Guide
2016
Completed Phase 2
~960

Find a Location

Who is running the clinical trial?

Stanford UniversityOTHER
2,386 Previous Clinical Trials
17,333,048 Total Patients Enrolled
University of California, IrvineLead Sponsor
542 Previous Clinical Trials
1,921,041 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,193 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)
Cornelia Pechmann 2016. "Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02823028.
~113 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top